PET-Dopa
What is PET-Dopa?
PET with 18F-DOPA is an advanced medical imaging technique that uses a
radiopharmaceutical called fluorodopa (18F-DOPA) to evaluate metabolic activity
in specific body tissues. This study is especially useful for
diagnosing and monitoring neurological diseases and certain types of
neuroendocrine tumors.
What is this test used for?
PET with 18F-DOPA is primarily used in:
- Neurology: Used for the diagnosis of neurodegenerative diseases such as Parkinson’s disease and for evaluating movement disorders related to the dopaminergic system.
- Oncology: Used to diagnose and locate neuroendocrine tumors, evaluate pheochromocytomas, paragangliomas, and other tumors derived from chromaffin cells, as well as to monitor metastases of neuroendocrine tumors.
- Endocrinology: Useful for studying congenital hyperinsulinism in children.
Benefits of high technology in PET with 18F-DOPA
18F-DOPA is an analog of dopamine, a key neurotransmitter in the
central nervous system. When administered intravenously, the radiopharmaceutical
accumulates in areas where there is metabolic activity related to dopamine or in tissues with high uptake, such as neuroendocrine tumors. The PET scanner
detects the radiation emitted by 18F-DOPA and generates three-dimensional
images that show areas of higher uptake.
How is the procedure performed?
The PET-FDG procedure involves:
-
Preparation:
Before the exam, you will need to fast for at least 6 hours to ensure that blood glucose levels are low and do not interfere with radiopharmaceutical uptake. It is also recommended to drink water before the study. Inform your doctor about any medications you are taking, especially those that may interfere with dopamine metabolism. If you are pregnant or breastfeeding, be sure to inform your doctor. Additionally, we suggest wearing comfortable clothing without metallic elements.
-
During the test:
During the test, 18F-DOPA will be administered intravenously. After the injection, you will need to rest for about 30-60 minutes to allow the radiopharmaceutical to distribute throughout your body. Then, you will be asked to lie on the PET scanner table while images are taken. It is important to remain still during the study to ensure image quality. The complete procedure, including preparation and imaging, will last approximately 2 hours.
-
After the test:
After the procedure, you can resume your normal activities, unless your doctor tells you otherwise. You are advised to drink plenty of water to help eliminate the radiopharmaceutical from your body. The results of the PET with 18F-DOPA will be reviewed by a specialized radiologist and sent to your doctor, who will explain the findings and suggest appropriate treatment, if necessary.
Recommendations for the test
Consult your doctor if you need to stop any medication before the exam. During the procedure, it is very important to remain as still as possible to ensure the accuracy of the images. Be sure to follow all your doctor’s instructions before, during, and after the procedure.
Are there any risks?
PET with 18F-DOPA is a safe procedure, but there are some minimal risks:
● Radiation exposure: 18F-DOPA emits a small amount of
radiation, but the dose is low and considered safe.
● Allergic reactions (rare): In exceptional cases, there may be
allergic reactions to the radiopharmaceutical.
● Mild discomfort: You may experience discomfort at the injection site.
For your test to proceed smoothly, we ask that you arrive in advance of your scheduled time. This will allow us to complete the necessary administrative and clinical preparation.
Before the test, we will provide you with the Informed Consent form, a document with important information that you must read and sign.
If your appointment is for a Magnetic Resonance Imaging (MRI), it is crucial that you inform us about the presence of pacemakers, metallic objects, prostheses (including dental), tattoos, or medication infusion devices, such as insulin pumps.
These diagnostic tests are very safe, but as with any medical procedure, there is a minimal possibility of incidence.
